About this trial
Sleep in the neonatal period is a fundamental biological requirement for regulating growth, neurodevelopment, and the immune system. However, disruptions in sleep patterns during this period are common among both term and preterm infants. Preterm infants have a more fragile sleep structure due to incomplete neurological maturation, while term infants may also experience sleep difficulties during the postnatal adaptation process. Improving sleep onset and sleep quality in newborns is crucial for the well-being and quality of life of both the infant and the family.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Premature infants who are clinically stable and between 26 and 37 weeks' gestational age.
Infants monitored in the neonatal intensive care unit (NICU).
A music-based intervention
Sleep outcomes and/or physiological parameters measured.
Disqualifiers
Non-neonatal infants (aged over 28 days). Term infants (≥37 weeks).
Non-neonatal age groups
Only assessing secondary outcomes, such as parental anxiety or caregiver stress
Case reports, conference abstracts, letters, etc.
Trial population
This meta-analysis includes preterm (gestational age 26-37 weeks) neonates who were exposed to music therapy, lullabies, or other sound-based interventions in randomized controlled or quasi-experimental studies.
Trial design
Other
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Sleep Quality in Neonates
\- Weight gain Sleep-related indicators: sleep duration, duration of quiet sleep, sleep-wake cycle and brain activity, as measured by aEEG.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: